fanta.bio Sample: CNhs11350
14972 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 987 / 10449 (9.4%) | 292 / 104490 (0.3%) | −324.0 | −324.0 | 33.80 |
| HIF1A SRX11007095 | HK-2 Kidney | 1841 / 10449 (17.6%) | 670 / 104490 (0.6%) | −324.0 | −324.0 | 27.48 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1404 / 10449 (13.4%) | 529 / 104490 (0.5%) | −324.0 | −324.0 | 26.54 |
| TP53 SRX19538279 | Osteoblasts Bone | 461 / 10449 (4.4%) | 187 / 104490 (0.2%) | −324.0 | −324.0 | 24.65 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1241 / 10449 (11.9%) | 588 / 104490 (0.6%) | −324.0 | −324.0 | 21.11 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 1737 / 10449 (16.6%) | 868 / 104490 (0.8%) | −324.0 | −324.0 | 20.01 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 1681 / 10449 (16.1%) | 869 / 104490 (0.8%) | −324.0 | −324.0 | 19.34 |
| SCML2 SRX644728 | 293 Kidney | 1008 / 10449 (9.6%) | 583 / 104490 (0.6%) | −324.0 | −324.0 | 17.29 |
| MYH11 SRX265221 | ME-1 Blood | 629 / 10449 (6.0%) | 428 / 104490 (0.4%) | −324.0 | −324.0 | 14.70 |
| FOXP1 SRX736067 | LNCAP Prostate | 1267 / 10449 (12.1%) | 872 / 104490 (0.8%) | −324.0 | −324.0 | 14.53 |
| MED1 SRX9419945 | BT-474 Breast | 2535 / 10449 (24.3%) | 1996 / 104490 (1.9%) | −324.0 | −324.0 | 12.70 |
| BRD4 SRX9419935 | BT-474 Breast | 2556 / 10449 (24.5%) | 2014 / 104490 (1.9%) | −324.0 | −324.0 | 12.69 |
| BRD4 SRX9419937 | BT-474 Breast | 2545 / 10449 (24.4%) | 2010 / 104490 (1.9%) | −324.0 | −324.0 | 12.66 |
| MED1 SRX9419944 | BT-474 Breast | 2498 / 10449 (23.9%) | 1979 / 104490 (1.9%) | −324.0 | −324.0 | 12.62 |
| MED1 SRX9419946 | BT-474 Breast | 2588 / 10449 (24.8%) | 2106 / 104490 (2.0%) | −324.0 | −324.0 | 12.29 |
| BRD4 SRX9419936 | BT-474 Breast | 2573 / 10449 (24.6%) | 2121 / 104490 (2.0%) | −324.0 | −324.0 | 12.13 |
| MED1 SRX9419947 | BT-474 Breast | 2495 / 10449 (23.9%) | 2059 / 104490 (2.0%) | −324.0 | −324.0 | 12.12 |
| BRD4 SRX9419938 | BT-474 Breast | 2541 / 10449 (24.3%) | 2100 / 104490 (2.0%) | −324.0 | −324.0 | 12.10 |
| BRD4 SRX736201 | 90-8TL Neural | 4287 / 10449 (41.0%) | 4535 / 104490 (4.3%) | −324.0 | −324.0 | 9.45 |
| EZH2 SRX2146136 | LNCAP Prostate | 5281 / 10449 (50.5%) | 5597 / 104490 (5.4%) | −324.0 | −324.0 | 9.44 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1296 / 10449 (12.4%) | 1745 / 104490 (1.7%) | −324.0 | −324.0 | 7.43 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1046 / 10449 (10.0%) | 2276 / 104490 (2.2%) | −299.8 | −296.6 | 4.60 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1209 / 10449 (11.6%) | 3182 / 104490 (3.0%) | −286.2 | −283.1 | 3.80 |
| TP53 SRX19538274 | U2OS Bone | 377 / 10449 (3.6%) | 123 / 104490 (0.1%) | −280.5 | −277.3 | 30.65 |
| TP53 SRX19538268 | U2OS Bone | 373 / 10449 (3.6%) | 117 / 104490 (0.1%) | −280.2 | −277.0 | 31.88 |
| TP53 SRX19538276 | U2OS Bone | 374 / 10449 (3.6%) | 130 / 104490 (0.1%) | −273.8 | −270.7 | 28.77 |
| HIF1A SRX20663235 | HK-2 Kidney | 394 / 10449 (3.8%) | 175 / 104490 (0.2%) | −269.2 | −266.1 | 22.51 |
| AGO2 SRX4708039 | Hep G2 Liver | 1432 / 10449 (13.7%) | 4593 / 104490 (4.4%) | −267.6 | −264.5 | 3.12 |
| TP53 SRX19538267 | U2OS Bone | 335 / 10449 (3.2%) | 104 / 104490 (0.1%) | −252.1 | −249.1 | 32.21 |
| TP53 SRX19538275 | U2OS Bone | 341 / 10449 (3.3%) | 116 / 104490 (0.1%) | −250.9 | −247.9 | 29.40 |
| TP53 SRX19538280 | Osteoblasts Bone | 358 / 10449 (3.4%) | 146 / 104490 (0.1%) | −250.8 | −247.7 | 24.52 |
| TP53 SRX19538273 | U2OS Bone | 327 / 10449 (3.1%) | 103 / 104490 (0.1%) | −245.2 | −242.2 | 31.75 |
| TP53 SRX19538281 | Osteoblasts Bone | 380 / 10449 (3.6%) | 207 / 104490 (0.2%) | −242.7 | −239.7 | 18.36 |
| IRF3 SRX11453858 | Hep G2 Liver | 287 / 10449 (2.7%) | 51 / 104490 (0.0%) | −241.4 | −238.4 | 56.27 |
| TP53 SRX19538269 | U2OS Bone | 412 / 10449 (3.9%) | 288 / 104490 (0.3%) | −239.3 | −236.4 | 14.31 |
| RUNX1 SRX2513054 | 293 Kidney | 2314 / 10449 (22.1%) | 10934 / 104490 (10.5%) | −231.8 | −228.9 | 2.12 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 507 / 10449 (4.9%) | 596 / 104490 (0.6%) | −227.6 | −224.7 | 8.51 |
| 5-mC SRX882970 | LNCAP Prostate | 2037 / 10449 (19.5%) | 9356 / 104490 (9.0%) | −213.1 | −210.2 | 2.18 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 489 / 10449 (4.7%) | 610 / 104490 (0.6%) | −211.6 | −208.7 | 8.02 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 1520 / 10449 (14.5%) | 5928 / 104490 (5.7%) | −211.1 | −208.1 | 2.56 |
| TP53 SRX19538270 | U2OS Bone | 372 / 10449 (3.6%) | 278 / 104490 (0.3%) | −209.9 | −207.0 | 13.38 |
| IRF3 SRX11453861 | Hep G2 Liver | 253 / 10449 (2.4%) | 55 / 104490 (0.1%) | −205.4 | −202.5 | 46.00 |
| 5-mC SRX882968 | LNCAP Prostate | 2010 / 10449 (19.2%) | 9329 / 104490 (8.9%) | −205.2 | −202.3 | 2.15 |
| TP53 SRX19538271 | U2OS Bone | 531 / 10449 (5.1%) | 789 / 104490 (0.8%) | −204.8 | −201.9 | 6.73 |
| CIC SRX13262055 | Astrocytes Neural | 2130 / 10449 (20.4%) | 10222 / 104490 (9.8%) | −203.5 | −200.6 | 2.08 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 311 / 10449 (3.0%) | 163 / 104490 (0.2%) | −201.2 | −198.3 | 19.08 |
| BRD4 SRX736204 | 90-8TL Neural | 770 / 10449 (7.4%) | 1859 / 104490 (1.8%) | −196.7 | −193.9 | 4.14 |
| PBX4 SRX2731658 | PC-3 Prostate | 600 / 10449 (5.7%) | 16209 / 104490 (15.5%) | −195.2 | −192.3 | 0.37 |
| TP53 SRX19538282 | Osteoblasts Bone | 322 / 10449 (3.1%) | 214 / 104490 (0.2%) | −190.7 | −187.9 | 15.05 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1030 / 10449 (9.9%) | 3341 / 104490 (3.2%) | −185.8 | −183.0 | 3.08 |
| 5-mC SRX882965 | LNCAP Prostate | 1650 / 10449 (15.8%) | 7261 / 104490 (6.9%) | −184.2 | −181.3 | 2.27 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 445 / 10449 (4.3%) | 614 / 104490 (0.6%) | −180.3 | −177.5 | 7.25 |
| AGO2 SRX6783958 | Hep G2 Liver | 906 / 10449 (8.7%) | 2727 / 104490 (2.6%) | −179.8 | −177.0 | 3.32 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 859 / 10449 (8.2%) | 2522 / 104490 (2.4%) | −175.7 | −172.9 | 3.41 |
| AGO2 SRX6783957 | Hep G2 Liver | 904 / 10449 (8.7%) | 2797 / 104490 (2.7%) | −173.0 | −170.2 | 3.23 |
| Epitope tags SRX10549776 | K-562 Blood | 989 / 10449 (9.5%) | 3275 / 104490 (3.1%) | −172.9 | −170.2 | 3.02 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1240 / 10449 (11.9%) | 4794 / 104490 (4.6%) | −172.0 | −169.3 | 2.59 |
| KAT6A SRX20971022 | Fibroblasts Others | 223 / 10449 (2.1%) | 68 / 104490 (0.1%) | −168.5 | −165.7 | 32.79 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1175 / 10449 (11.2%) | 4503 / 104490 (4.3%) | −165.0 | −162.2 | 2.61 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1368 / 10449 (13.1%) | 5740 / 104490 (5.5%) | −164.9 | −162.2 | 2.38 |
| SREBF2 SRX5359048 | HCC70 Breast | 1202 / 10449 (11.5%) | 4696 / 104490 (4.5%) | −163.5 | −160.8 | 2.56 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 1336 / 10449 (12.8%) | 5591 / 104490 (5.4%) | −161.6 | −158.9 | 2.39 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 1281 / 10449 (12.3%) | 5254 / 104490 (5.0%) | −160.3 | −157.5 | 2.44 |
| FOXA1 SRX4815198 | MCF-7 Breast | 595 / 10449 (5.7%) | 14886 / 104490 (14.2%) | −158.7 | −156.0 | 0.40 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 215 / 10449 (2.1%) | 79 / 104490 (0.1%) | −154.9 | −152.2 | 27.22 |
| TP53 SRX19538272 | U2OS Bone | 436 / 10449 (4.2%) | 734 / 104490 (0.7%) | −153.0 | −150.3 | 5.94 |
| KAT7 SRX101303 | RKO Digestive tract | 925 / 10449 (8.9%) | 3198 / 104490 (3.1%) | −151.3 | −148.6 | 2.89 |
| MECOM SRX23677897 | HNT-34 Blood | 1405 / 10449 (13.4%) | 6272 / 104490 (6.0%) | −150.0 | −147.3 | 2.24 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 346 / 10449 (3.3%) | 433 / 104490 (0.4%) | −149.1 | −146.4 | 7.99 |
| TRP47 SRX4548329 | THP-1 Blood | 1719 / 10449 (16.5%) | 8515 / 104490 (8.1%) | −148.3 | −145.6 | 2.02 |
| BRD1 SRX286203 | RKO Digestive tract | 811 / 10449 (7.8%) | 2594 / 104490 (2.5%) | −147.8 | −145.1 | 3.13 |
| FOS SRX150477 | MCF 10A Breast | 429 / 10449 (4.1%) | 12016 / 104490 (11.5%) | −147.2 | −144.6 | 0.36 |
| BRPF3 SRX796084 | RKO Digestive tract | 1027 / 10449 (9.8%) | 3873 / 104490 (3.7%) | −147.1 | −144.4 | 2.65 |
| MECOM SRX23677885 | HNT-34 Blood | 1212 / 10449 (11.6%) | 5054 / 104490 (4.8%) | −146.5 | −143.9 | 2.40 |
| CDYL2 SRX8321653 | MCF-7 Breast | 1245 / 10449 (11.9%) | 5288 / 104490 (5.1%) | −145.6 | −143.0 | 2.35 |
| FOS SRX150478 | MCF 10A Breast | 456 / 10449 (4.4%) | 12366 / 104490 (11.8%) | −145.4 | −142.7 | 0.37 |
| MITF SRX1555436 | 501A Epidermis | 1310 / 10449 (12.5%) | 5731 / 104490 (5.5%) | −145.0 | −142.3 | 2.29 |
| RUNX1 SRX2014504 | Jurkat Blood | 1620 / 10449 (15.5%) | 7887 / 104490 (7.5%) | −144.6 | −142.0 | 2.05 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 582 / 10449 (5.6%) | 1434 / 104490 (1.4%) | −144.6 | −142.0 | 4.06 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1081 / 10449 (10.3%) | 4261 / 104490 (4.1%) | −143.9 | −141.3 | 2.54 |
| MECOM SRX23677896 | HNT-34 Blood | 1431 / 10449 (13.7%) | 6588 / 104490 (6.3%) | −143.4 | −140.7 | 2.17 |
| FOXA1 SRX4815197 | MCF-7 Breast | 440 / 10449 (4.2%) | 12028 / 104490 (11.5%) | −142.6 | −140.0 | 0.37 |
| MECOM SRX23677884 | HNT-34 Blood | 1188 / 10449 (11.4%) | 4978 / 104490 (4.8%) | −142.1 | −139.5 | 2.39 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 349 / 10449 (3.3%) | 477 / 104490 (0.5%) | −142.1 | −139.5 | 7.32 |
| FOXA1 SRX176862 | MCF-7 Breast | 227 / 10449 (2.2%) | 8496 / 104490 (8.1%) | −140.1 | −137.5 | 0.27 |
| BMI1 SRX7196721 | SF8628 Neural | 1164 / 10449 (11.1%) | 4862 / 104490 (4.7%) | −140.0 | −137.4 | 2.39 |
| PTEN SRX5416007 | SMMC-7721 Liver | 1217 / 10449 (11.6%) | 5231 / 104490 (5.0%) | −138.8 | −136.2 | 2.33 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 1164 / 10449 (11.1%) | 4913 / 104490 (4.7%) | −137.2 | −134.6 | 2.37 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 1205 / 10449 (11.5%) | 5226 / 104490 (5.0%) | −135.0 | −132.4 | 2.31 |
| FOXA1 SRX176863 | MCF-7 Breast | 211 / 10449 (2.0%) | 8051 / 104490 (7.7%) | −134.6 | −132.1 | 0.26 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 422 / 10449 (4.0%) | 11454 / 104490 (11.0%) | −134.0 | −131.5 | 0.37 |
| BRPF3 SRX796086 | RKO Digestive tract | 960 / 10449 (9.2%) | 3688 / 104490 (3.5%) | −132.8 | −130.3 | 2.60 |
| AR SRX10820653 | LNCAP Prostate | 222 / 10449 (2.1%) | 144 / 104490 (0.1%) | −132.8 | −130.2 | 15.42 |
| BRPF3 SRX796085 | RKO Digestive tract | 723 / 10449 (6.9%) | 2298 / 104490 (2.2%) | −132.4 | −129.9 | 3.15 |
| ESR1 SRX4367193 | MCF-7 Breast | 639 / 10449 (6.1%) | 14548 / 104490 (13.9%) | −132.2 | −129.7 | 0.44 |
| ING5 SRX286202 | RKO Digestive tract | 883 / 10449 (8.5%) | 3228 / 104490 (3.1%) | −132.1 | −129.6 | 2.74 |
| ESR1 SRX371471 | ZR-75-1 Breast | 198 / 10449 (1.9%) | 7661 / 104490 (7.3%) | −129.4 | −126.8 | 0.26 |
| ERG SRX063922 | K-562 Blood | 1054 / 10449 (10.1%) | 4346 / 104490 (4.2%) | −129.1 | −126.5 | 2.43 |
| ESR1 SRX371469 | MCF-7 Breast | 194 / 10449 (1.9%) | 7519 / 104490 (7.2%) | −127.2 | −124.7 | 0.26 |
| MEAF6 DRX234811 | 293 Kidney | 1103 / 10449 (10.6%) | 4709 / 104490 (4.5%) | −126.7 | −124.2 | 2.34 |
| ESR1 SRX371478 | MCF-7 Breast | 247 / 10449 (2.4%) | 8424 / 104490 (8.1%) | −126.7 | −124.2 | 0.29 |
| FOXA1 SRX371481 | MCF-7 Breast | 198 / 10449 (1.9%) | 7568 / 104490 (7.2%) | −126.4 | −123.8 | 0.26 |
| ESR1 SRX7624157 | MCF-7 Breast | 518 / 10449 (5.0%) | 12598 / 104490 (12.1%) | −126.2 | −123.7 | 0.41 |
| TRIM25 SRX1660872 | Breast cancer cells Breast | 1098 / 10449 (10.5%) | 4704 / 104490 (4.5%) | −125.2 | −122.7 | 2.33 |
| FOXA1 SRX3931044 | MCF-7 Breast | 428 / 10449 (4.1%) | 11191 / 104490 (10.7%) | −123.9 | −121.4 | 0.38 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 218 / 10449 (2.1%) | 7817 / 104490 (7.5%) | −123.3 | −120.8 | 0.28 |
| STAT5B SRX831881 | CD8+ T cells Blood | 187 / 10449 (1.8%) | 93 / 104490 (0.1%) | −123.2 | −120.7 | 20.11 |
| ESR1 SRX371470 | ZR-75-1 Breast | 169 / 10449 (1.6%) | 6947 / 104490 (6.6%) | −123.0 | −120.5 | 0.24 |
| NABP2 SRX9523535 | HT-1080 Bone | 918 / 10449 (8.8%) | 3589 / 104490 (3.4%) | −122.9 | −120.4 | 2.56 |
| YAP1 SRX757325 | H2052 Lung | 529 / 10449 (5.1%) | 12630 / 104490 (12.1%) | −122.8 | −120.3 | 0.42 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 433 / 10449 (4.1%) | 933 / 104490 (0.9%) | −122.8 | −120.3 | 4.64 |
| FOXA1 SRX371483 | MCF-7 Breast | 220 / 10449 (2.1%) | 7830 / 104490 (7.5%) | −122.6 | −120.1 | 0.28 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 136 / 10449 (1.3%) | 6315 / 104490 (6.0%) | −122.5 | −120.1 | 0.22 |
| AR SRX10820651 | LNCAP Prostate | 237 / 10449 (2.3%) | 215 / 104490 (0.2%) | −122.1 | −119.7 | 11.02 |
| FOS SRX4192880 | MCF 10A Breast | 340 / 10449 (3.3%) | 9763 / 104490 (9.3%) | −121.7 | −119.2 | 0.35 |
| LEO1 SRX1873456 | SEM Blood | 962 / 10449 (9.2%) | 3889 / 104490 (3.7%) | −121.6 | −119.2 | 2.47 |
| TLE3 SRX4815191 | MCF-7 Breast | 182 / 10449 (1.7%) | 7126 / 104490 (6.8%) | −121.3 | −118.9 | 0.26 |
| TP53 SRX396254 | Fibroblasts Others | 593 / 10449 (5.7%) | 1728 / 104490 (1.7%) | −121.2 | −118.8 | 3.43 |
| MECOM SRX23677890 | HNT-34 Blood | 1182 / 10449 (11.3%) | 5352 / 104490 (5.1%) | −121.0 | −118.5 | 2.21 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 356 / 10449 (3.4%) | 628 / 104490 (0.6%) | −120.2 | −117.8 | 5.67 |
| FOXA1 SRX1161177 | MCF-7 Breast | 194 / 10449 (1.9%) | 7296 / 104490 (7.0%) | −120.0 | −117.5 | 0.27 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 821 / 10449 (7.9%) | 3044 / 104490 (2.9%) | −119.8 | −117.3 | 2.70 |
| ESR1 SRX20282961 | MCF-7 Breast | 253 / 10449 (2.4%) | 8298 / 104490 (7.9%) | −119.7 | −117.3 | 0.30 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 233 / 10449 (2.2%) | 7909 / 104490 (7.6%) | −118.1 | −115.6 | 0.29 |
| ESR1 SRX176861 | MCF-7 Breast | 342 / 10449 (3.3%) | 9657 / 104490 (9.2%) | −117.7 | −115.3 | 0.35 |
| ESR1 SRX176860 | MCF-7 Breast | 339 / 10449 (3.2%) | 9598 / 104490 (9.2%) | −117.3 | −114.8 | 0.35 |
| ESR1 SRX20282960 | MCF-7 Breast | 229 / 10449 (2.2%) | 7814 / 104490 (7.5%) | −117.2 | −114.7 | 0.29 |
| ERG SRX063921 | K-562 Blood | 981 / 10449 (9.4%) | 4090 / 104490 (3.9%) | −117.1 | −114.7 | 2.40 |
| MECOM SRX23677891 | HNT-34 Blood | 1159 / 10449 (11.1%) | 5285 / 104490 (5.1%) | −116.7 | −114.3 | 2.19 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 425 / 10449 (4.1%) | 947 / 104490 (0.9%) | −116.6 | −114.2 | 4.49 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 1020 / 10449 (9.8%) | 4364 / 104490 (4.2%) | −116.2 | −113.8 | 2.34 |
| MEAF6 DRX300417 | 293 Kidney | 996 / 10449 (9.5%) | 4205 / 104490 (4.0%) | −116.2 | −113.8 | 2.37 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 1211 / 10449 (11.6%) | 5655 / 104490 (5.4%) | −116.0 | −113.6 | 2.14 |
| ESR1 SRX194569 | MCF-7 Breast | 209 / 10449 (2.0%) | 7429 / 104490 (7.1%) | −115.8 | −113.4 | 0.28 |
| FOXA1 SRX371482 | MCF-7 Breast | 299 / 10449 (2.9%) | 8894 / 104490 (8.5%) | −115.2 | −112.8 | 0.34 |
| ATF3 SRX2207918 | CS1AN Epidermis | 1453 / 10449 (13.9%) | 7407 / 104490 (7.1%) | −114.7 | −112.3 | 1.96 |
| ESR1 SRX371467 | MCF-7 Breast | 214 / 10449 (2.0%) | 7464 / 104490 (7.1%) | −114.3 | −111.9 | 0.29 |
| ESR1 SRX7624156 | MCF-7 Breast | 336 / 10449 (3.2%) | 9442 / 104490 (9.0%) | −114.2 | −111.9 | 0.36 |
| YAP1 SRX757326 | H2052 Lung | 460 / 10449 (4.4%) | 11303 / 104490 (10.8%) | −114.0 | −111.6 | 0.41 |
| CXXC1 SRX1424886 | SEM Blood | 946 / 10449 (9.1%) | 3925 / 104490 (3.8%) | −113.9 | −111.5 | 2.41 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 1305 / 10449 (12.5%) | 6372 / 104490 (6.1%) | −113.5 | −111.1 | 2.05 |
| KMT2A SRX2323891 | 293 Kidney | 648 / 10449 (6.2%) | 2124 / 104490 (2.0%) | −113.2 | −110.9 | 3.05 |
| ESR1 SRX371476 | MCF-7 Breast | 148 / 10449 (1.4%) | 6258 / 104490 (6.0%) | −113.1 | −110.7 | 0.24 |
| FOXA1 SRX1161173 | MCF-7 Breast | 155 / 10449 (1.5%) | 6367 / 104490 (6.1%) | −112.4 | −110.1 | 0.24 |
| Crotonyllysine SRX19488269 | GSC23 Neural | 797 / 10449 (7.6%) | 3019 / 104490 (2.9%) | −112.1 | −109.7 | 2.64 |
| GATA3 SRX190239 | MCF-7 Breast | 310 / 10449 (3.0%) | 8943 / 104490 (8.6%) | −111.6 | −109.2 | 0.35 |
| ESR1 SRX1531791 | MCF-7 Breast | 200 / 10449 (1.9%) | 7117 / 104490 (6.8%) | −110.9 | −108.5 | 0.28 |
| ESR1 SRX20282939 | MCF-7 Breast | 240 / 10449 (2.3%) | 7780 / 104490 (7.4%) | −110.6 | −108.2 | 0.31 |
| SSRP1 SRX3436567 | HT-1080 Bone | 264 / 10449 (2.5%) | 346 / 104490 (0.3%) | −110.5 | −108.1 | 7.63 |
| Epitope tags SRX10549778 | K-562 Blood | 720 / 10449 (6.9%) | 2586 / 104490 (2.5%) | −110.0 | −107.6 | 2.78 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 446 / 10449 (4.3%) | 1104 / 104490 (1.1%) | −109.9 | −107.5 | 4.04 |
| ZFX SRX7805372 | 293 Kidney | 986 / 10449 (9.4%) | 4263 / 104490 (4.1%) | −109.8 | −107.5 | 2.31 |
| ESR1 SRX371468 | MCF-7 Breast | 125 / 10449 (1.2%) | 5726 / 104490 (5.5%) | −109.8 | −107.4 | 0.22 |
| ESR1 SRX194572 | MCF-7 Breast | 123 / 10449 (1.2%) | 5687 / 104490 (5.4%) | −109.6 | −107.3 | 0.22 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 468 / 10449 (4.5%) | 11248 / 104490 (10.8%) | −109.5 | −107.1 | 0.42 |
| FOXA1 SRX1161176 | MCF-7 Breast | 198 / 10449 (1.9%) | 7013 / 104490 (6.7%) | −108.7 | −106.4 | 0.28 |
| Epitope tags DRX443510 | 293 Kidney | 923 / 10449 (8.8%) | 3873 / 104490 (3.7%) | −108.6 | −106.3 | 2.38 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 574 / 10449 (5.5%) | 1778 / 104490 (1.7%) | −108.3 | −106.0 | 3.23 |
| ESR1 SRX371479 | MCF-7 Breast | 197 / 10449 (1.9%) | 6976 / 104490 (6.7%) | −108.0 | −105.7 | 0.28 |
| FOXA1 SRX1787653 | MCF-7 Breast | 162 / 10449 (1.6%) | 6351 / 104490 (6.1%) | −107.8 | −105.5 | 0.26 |
| Epitope tags SRX2867680 | 293 Kidney | 1310 / 10449 (12.5%) | 6549 / 104490 (6.3%) | −107.6 | −105.3 | 2.00 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 361 / 10449 (3.5%) | 9595 / 104490 (9.2%) | −107.6 | −105.3 | 0.38 |
| RORC SRX5359053 | HCC70 Breast | 807 / 10449 (7.7%) | 3155 / 104490 (3.0%) | −107.6 | −105.3 | 2.56 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 895 / 10449 (8.6%) | 3713 / 104490 (3.6%) | −107.5 | −105.2 | 2.41 |
| RBFOX2 SRX4708082 | K-562 Blood | 1475 / 10449 (14.1%) | 7764 / 104490 (7.4%) | −107.4 | −105.1 | 1.90 |
| ESR1 SRX371477 | MCF-7 Breast | 94 / 10449 (0.9%) | 5047 / 104490 (4.8%) | −107.3 | −105.0 | 0.19 |
| LARP7 SRX2198835 | HeLa Uterus | 1323 / 10449 (12.7%) | 6663 / 104490 (6.4%) | −106.9 | −104.6 | 1.99 |
| Epitope tags SRX14024875 | Mesenchymal stem cells Others | 1140 / 10449 (10.9%) | 5385 / 104490 (5.2%) | −106.1 | −103.8 | 2.12 |
| ESR1 SRX20282954 | MCF-7 Breast | 234 / 10449 (2.2%) | 7513 / 104490 (7.2%) | −105.4 | −103.1 | 0.31 |
| RBFOX2 SRX4708034 | Hep G2 Liver | 1206 / 10449 (11.5%) | 5866 / 104490 (5.6%) | −105.3 | −103.0 | 2.06 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 695 / 10449 (6.7%) | 2511 / 104490 (2.4%) | −105.2 | −102.9 | 2.77 |
| RORC SRX5359052 | HCC70 Breast | 822 / 10449 (7.9%) | 3289 / 104490 (3.1%) | −105.1 | −102.8 | 2.50 |
| GRHL3 SRX2582162 | NHEK Epidermis | 684 / 10449 (6.5%) | 2450 / 104490 (2.3%) | −104.9 | −102.6 | 2.79 |
| GATA3 SRX176864 | MCF-7 Breast | 153 / 10449 (1.5%) | 6101 / 104490 (5.8%) | −104.9 | −102.6 | 0.25 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 198 / 10449 (1.9%) | 6855 / 104490 (6.6%) | −103.8 | −101.5 | 0.29 |
| AR SRX1067071 | LHSAR Prostate | 434 / 10449 (4.2%) | 10524 / 104490 (10.1%) | −103.4 | −101.1 | 0.41 |
| KMT2A SRX2281249 | SEM Blood | 1209 / 10449 (11.6%) | 5932 / 104490 (5.7%) | −103.4 | −101.1 | 2.04 |
| MethylCap SRX014767 | NB-4 Blood | 1066 / 10449 (10.2%) | 4936 / 104490 (4.7%) | −103.3 | −101.0 | 2.16 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 311 / 10449 (3.0%) | 8671 / 104490 (8.3%) | −103.3 | −101.0 | 0.36 |
| TET2 SRX1427029 | 293 Kidney | 816 / 10449 (7.8%) | 3292 / 104490 (3.2%) | −102.9 | −100.6 | 2.48 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 839 / 10449 (8.0%) | 3439 / 104490 (3.3%) | −102.9 | −100.6 | 2.44 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 210 / 10449 (2.0%) | 7024 / 104490 (6.7%) | −102.7 | −100.5 | 0.30 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 150 / 10449 (1.4%) | 5980 / 104490 (5.7%) | −102.7 | −100.4 | 0.25 |
| FOXA1 SRX3931043 | MCF-7 Breast | 219 / 10449 (2.1%) | 7168 / 104490 (6.9%) | −102.5 | −100.2 | 0.31 |
| NFYB SRX16608147 | HeLa Uterus | 180 / 10449 (1.7%) | 132 / 104490 (0.1%) | −102.4 | −100.2 | 13.64 |
| RAC1 SRX10365541 | MCF-7 Breast | 107 / 10449 (1.0%) | 5162 / 104490 (4.9%) | −102.4 | −100.1 | 0.21 |
| Epitope tags SRX392691 | T3M-1 Cl-10 Others | 144 / 10449 (1.4%) | 56 / 104490 (0.1%) | −102.3 | −100.1 | 25.71 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 92 / 10449 (0.9%) | 4860 / 104490 (4.7%) | −102.2 | −100.0 | 0.19 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 327 / 10449 (3.1%) | 8873 / 104490 (8.5%) | −102.0 | −99.8 | 0.37 |
| AR SRX9469988 | LAPC-4 Prostate | 294 / 10449 (2.8%) | 8333 / 104490 (8.0%) | −101.2 | −98.9 | 0.35 |
| ESR1 SRX2943591 | MCF-7 Breast | 148 / 10449 (1.4%) | 5892 / 104490 (5.6%) | −101.0 | −98.8 | 0.25 |
| FOS SRX150517 | MCF 10A Breast | 389 / 10449 (3.7%) | 9760 / 104490 (9.3%) | −100.6 | −98.3 | 0.40 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 368 / 10449 (3.5%) | 9441 / 104490 (9.0%) | −100.4 | −98.2 | 0.39 |
| FOXA1 SRX371480 | MCF-7 Breast | 146 / 10449 (1.4%) | 5838 / 104490 (5.6%) | −100.4 | −98.2 | 0.25 |
| CDK9 SRX7366783 | MCF-7 Breast | 166 / 10449 (1.6%) | 105 / 104490 (0.1%) | −100.4 | −98.1 | 15.81 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 286 / 10449 (2.7%) | 8177 / 104490 (7.8%) | −100.4 | −98.1 | 0.35 |
| GATA3 SRX5057632 | MCF-7 Breast | 139 / 10449 (1.3%) | 5697 / 104490 (5.5%) | −100.0 | −97.7 | 0.24 |
| RAC1 SRX10365543 | MCF-7 Breast | 113 / 10449 (1.1%) | 5203 / 104490 (5.0%) | −99.8 | −97.6 | 0.22 |
| PGR SRX1012655 | MCF-7 Breast | 134 / 10449 (1.3%) | 5588 / 104490 (5.3%) | −99.4 | −97.2 | 0.24 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 140 / 10449 (1.3%) | 55 / 104490 (0.1%) | −99.2 | −97.0 | 25.45 |
| FOXA1 SRX1161175 | MCF-7 Breast | 162 / 10449 (1.6%) | 6080 / 104490 (5.8%) | −99.1 | −96.9 | 0.27 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 215 / 10449 (2.1%) | 6981 / 104490 (6.7%) | −98.9 | −96.7 | 0.31 |
| FOXA1 SRX028634 | MCF-7 Breast | 96 / 10449 (0.9%) | 4840 / 104490 (4.6%) | −98.8 | −96.6 | 0.20 |
| Epitope tags SRX10549777 | K-562 Blood | 1500 / 10449 (14.4%) | 8191 / 104490 (7.8%) | −98.7 | −96.5 | 1.83 |
| FOXA1 SRX1787655 | MCF-7 Breast | 100 / 10449 (1.0%) | 4916 / 104490 (4.7%) | −98.6 | −96.4 | 0.20 |
| ARID1A SRX5089376 | MCF-7 Breast | 190 / 10449 (1.8%) | 6552 / 104490 (6.3%) | −98.6 | −96.4 | 0.29 |
| FOXA1 SRX100506 | Hep G2 Liver | 296 / 10449 (2.8%) | 8271 / 104490 (7.9%) | −98.5 | −96.3 | 0.36 |
| NR2F2 SRX190293 | MCF-7 Breast | 238 / 10449 (2.3%) | 7342 / 104490 (7.0%) | −98.4 | −96.1 | 0.32 |
| MED1 SRX4937336 | HCT 116 Digestive tract | 977 / 10449 (9.4%) | 4438 / 104490 (4.2%) | −98.2 | −96.0 | 2.20 |
| DOT1L SRX10606583 | GIST-T1 Digestive tract | 766 / 10449 (7.3%) | 3060 / 104490 (2.9%) | −98.0 | −95.8 | 2.50 |
| TLE3 SRX4815192 | MCF-7 Breast | 198 / 10449 (1.9%) | 6665 / 104490 (6.4%) | −97.9 | −95.7 | 0.30 |
| PHF6 SRX11508321 | G-401 Kidney | 954 / 10449 (9.1%) | 4292 / 104490 (4.1%) | −97.8 | −95.6 | 2.22 |
| ESR1 SRX20282972 | MCF-7 Breast | 256 / 10449 (2.4%) | 7614 / 104490 (7.3%) | −97.7 | −95.5 | 0.34 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 167 / 10449 (1.6%) | 6125 / 104490 (5.9%) | −97.6 | −95.5 | 0.27 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 204 / 10449 (2.0%) | 6756 / 104490 (6.5%) | −97.6 | −95.4 | 0.30 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 480 / 10449 (4.6%) | 1402 / 104490 (1.3%) | −97.6 | −95.4 | 3.42 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 508 / 10449 (4.9%) | 1553 / 104490 (1.5%) | −97.4 | −95.2 | 3.27 |
| GRHL3 SRX2582161 | NHEK Epidermis | 567 / 10449 (5.4%) | 1879 / 104490 (1.8%) | −97.3 | −95.1 | 3.02 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 101 / 10449 (1.0%) | 4897 / 104490 (4.7%) | −97.3 | −95.1 | 0.21 |
| FOXA1 SRX1787652 | MCF-7 Breast | 127 / 10449 (1.2%) | 5390 / 104490 (5.2%) | −97.2 | −95.1 | 0.24 |
| FOXA2 SRX100448 | Hep G2 Liver | 245 / 10449 (2.3%) | 7415 / 104490 (7.1%) | −97.2 | −95.0 | 0.33 |
| CHD6 SRX17709200 | C4-2 Prostate | 965 / 10449 (9.2%) | 4382 / 104490 (4.2%) | −97.1 | −94.9 | 2.20 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 206 / 10449 (2.0%) | 6770 / 104490 (6.5%) | −97.0 | −94.8 | 0.30 |
| FOXA1 SRX5323843 | MCF-7 Breast | 104 / 10449 (1.0%) | 4942 / 104490 (4.7%) | −96.8 | −94.7 | 0.21 |
| CBFB SRX265218 | ME-1 Blood | 907 / 10449 (8.7%) | 4000 / 104490 (3.8%) | −96.7 | −94.5 | 2.27 |
| RBFOX2 SRX3323050 | Hep G2 Liver | 963 / 10449 (9.2%) | 4382 / 104490 (4.2%) | −96.4 | −94.2 | 2.20 |
| ESR1 SRX10365536 | MCF-7 Breast | 115 / 10449 (1.1%) | 5117 / 104490 (4.9%) | −95.6 | −93.5 | 0.22 |
| MEN1 SRX11712604 | K-562 Blood | 872 / 10449 (8.3%) | 3791 / 104490 (3.6%) | −95.5 | −93.3 | 2.30 |
| EP300 SRX1012648 | MCF-7 Breast | 99 / 10449 (0.9%) | 4806 / 104490 (4.6%) | −95.5 | −93.3 | 0.21 |
| FOXA1 SRX1787651 | MCF-7 Breast | 119 / 10449 (1.1%) | 5187 / 104490 (5.0%) | −95.5 | −93.3 | 0.23 |
| ING2 SRX286201 | RKO Digestive tract | 868 / 10449 (8.3%) | 3771 / 104490 (3.6%) | −95.2 | −93.1 | 2.30 |
| FOXA1 SRX1161174 | MCF-7 Breast | 236 / 10449 (2.3%) | 7201 / 104490 (6.9%) | −95.2 | −93.0 | 0.33 |
| JADE3 DRX300415 | 293 Kidney | 928 / 10449 (8.9%) | 4172 / 104490 (4.0%) | −95.1 | −92.9 | 2.22 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 155 / 10449 (1.5%) | 5830 / 104490 (5.6%) | −95.0 | −92.9 | 0.27 |
| CDK9 SRX7366781 | MCF-7 Breast | 156 / 10449 (1.5%) | 98 / 104490 (0.1%) | −94.6 | −92.5 | 15.92 |
| ESR1 SRX10365535 | MCF-7 Breast | 186 / 10449 (1.8%) | 6352 / 104490 (6.1%) | −94.6 | −92.5 | 0.29 |
| FOXA1 SRX3931055 | MCF-7 Breast | 188 / 10449 (1.8%) | 6385 / 104490 (6.1%) | −94.5 | −92.4 | 0.29 |
| ESR1 SRX371474 | BT-474 Breast | 97 / 10449 (0.9%) | 4731 / 104490 (4.5%) | −94.3 | −92.2 | 0.21 |
| ESR1 SRX1012632 | MCF-7 Breast | 102 / 10449 (1.0%) | 4829 / 104490 (4.6%) | −94.2 | −92.1 | 0.21 |
| AR SRX1067070 | LHSAR Prostate | 571 / 10449 (5.5%) | 12084 / 104490 (11.6%) | −93.9 | −91.8 | 0.47 |
| ESR1 SRX330067 | MCF-7 Breast | 206 / 10449 (2.0%) | 6669 / 104490 (6.4%) | −93.9 | −91.8 | 0.31 |
| ESR1 SRX20282955 | MCF-7 Breast | 244 / 10449 (2.3%) | 7286 / 104490 (7.0%) | −93.9 | −91.7 | 0.33 |
| SETD1A SRX23734379 | MOLM-13 Blood | 761 / 10449 (7.3%) | 3103 / 104490 (3.0%) | −93.9 | −91.7 | 2.45 |
| ESR1 SRX4367192 | MCF-7 Breast | 476 / 10449 (4.6%) | 10758 / 104490 (10.3%) | −93.8 | −91.7 | 0.44 |
| ESR1 SRX371475 | BT-474 Breast | 109 / 10449 (1.0%) | 4943 / 104490 (4.7%) | −93.6 | −91.5 | 0.22 |
| DNA-RNA hybrid SRX14756935 | MDA-MB-436 Breast | 366 / 10449 (3.5%) | 875 / 104490 (0.8%) | −93.5 | −91.3 | 4.18 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 202 / 10449 (1.9%) | 6573 / 104490 (6.3%) | −93.2 | −91.0 | 0.31 |
| ESR1 SRX2943589 | MCF-7 Breast | 109 / 10449 (1.0%) | 4926 / 104490 (4.7%) | −93.1 | −91.0 | 0.22 |
| ESR1 SRX20282946 | MCF-7 Breast | 133 / 10449 (1.3%) | 5374 / 104490 (5.1%) | −93.1 | −90.9 | 0.25 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 295 / 10449 (2.8%) | 8058 / 104490 (7.7%) | −93.0 | −90.9 | 0.37 |
| FOXA1 SRX3931054 | MCF-7 Breast | 215 / 10449 (2.1%) | 6783 / 104490 (6.5%) | −92.9 | −90.8 | 0.32 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 184 / 10449 (1.8%) | 6251 / 104490 (6.0%) | −92.5 | −90.4 | 0.29 |
| ESR1 SRX2881002 | MCF-7 Breast | 221 / 10449 (2.1%) | 6865 / 104490 (6.6%) | −92.5 | −90.4 | 0.32 |
| BMI1 SRX644729 | 293 Kidney | 159 / 10449 (1.5%) | 111 / 104490 (0.1%) | −92.5 | −90.3 | 14.32 |
| FOXA1 SRX3923514 | MCF-7 Breast | 233 / 10449 (2.2%) | 7057 / 104490 (6.8%) | −92.3 | −90.2 | 0.33 |
| FOXA2 SRX3230382 | Hep G2 Liver | 319 / 10449 (3.1%) | 8392 / 104490 (8.0%) | −92.0 | −89.9 | 0.38 |
| FOXA1 SRX100454 | T-47D Breast | 306 / 10449 (2.9%) | 8193 / 104490 (7.8%) | −92.0 | −89.9 | 0.37 |
| MethylCap SRX014766 | NB-4 Blood | 949 / 10449 (9.1%) | 4382 / 104490 (4.2%) | −92.0 | −89.9 | 2.17 |
| ESR1 SRX20282940 | MCF-7 Breast | 259 / 10449 (2.5%) | 7448 / 104490 (7.1%) | −91.6 | −89.5 | 0.35 |
| EP300 SRX176885 | MCF-7 Breast | 117 / 10449 (1.1%) | 5033 / 104490 (4.8%) | −91.5 | −89.4 | 0.23 |
| CDK9 SRX20230567 | Ishikawa Uterus | 1064 / 10449 (10.2%) | 5195 / 104490 (5.0%) | −91.3 | −89.2 | 2.05 |
| CHD6 SRX17709201 | C4-2 Prostate | 921 / 10449 (8.8%) | 4208 / 104490 (4.0%) | −91.2 | −89.1 | 2.19 |
| KAT6A DRX366108 | 293 Kidney | 1038 / 10449 (9.9%) | 5017 / 104490 (4.8%) | −91.1 | −89.0 | 2.07 |
| Epitope tags SRX2255894 | 293 Kidney | 812 / 10449 (7.8%) | 3485 / 104490 (3.3%) | −91.0 | −88.9 | 2.33 |
| ESR1 SRX4451213 | MCF-7 Breast | 236 / 10449 (2.3%) | 7055 / 104490 (6.8%) | −90.9 | −88.8 | 0.33 |
| ESR1 SRX20282973 | MCF-7 Breast | 287 / 10449 (2.7%) | 7854 / 104490 (7.5%) | −90.7 | −88.6 | 0.37 |
| Epitope tags SRX8030771 | 293 Kidney | 988 / 10449 (9.5%) | 4679 / 104490 (4.5%) | −90.7 | −88.6 | 2.11 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 336 / 10449 (3.2%) | 762 / 104490 (0.7%) | −90.5 | −88.4 | 4.41 |
| CDK9 SRX20230574 | Ishikawa Uterus | 906 / 10449 (8.7%) | 4131 / 104490 (4.0%) | −90.1 | −88.0 | 2.19 |
| FOXA1 SRX11222441 | MCF-7 Breast | 176 / 10449 (1.7%) | 6028 / 104490 (5.8%) | −89.8 | −87.7 | 0.29 |
| TET2 SRX2014505 | Jurkat Blood | 1561 / 10449 (14.9%) | 8930 / 104490 (8.5%) | −89.8 | −87.7 | 1.75 |
| ESR1 SRX10365532 | MCF-7 Breast | 123 / 10449 (1.2%) | 5086 / 104490 (4.9%) | −89.7 | −87.7 | 0.24 |
| GATA3 SRX6712581 | MCF-7 Breast | 193 / 10449 (1.8%) | 6310 / 104490 (6.0%) | −89.7 | −87.6 | 0.31 |
| CDK9 SRX20230570 | Ishikawa Uterus | 1023 / 10449 (9.8%) | 4949 / 104490 (4.7%) | −89.6 | −87.5 | 2.07 |
| FOS SRX150476 | MCF 10A Breast | 419 / 10449 (4.0%) | 9778 / 104490 (9.4%) | −89.6 | −87.5 | 0.43 |
| AR SRX1067066 | LHSAR Prostate | 498 / 10449 (4.8%) | 10885 / 104490 (10.4%) | −89.3 | −87.2 | 0.46 |
| GFP SRX12567758 | MRC-5 Lung | 915 / 10449 (8.8%) | 4208 / 104490 (4.0%) | −89.2 | −87.2 | 2.17 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 318 / 10449 (3.0%) | 8270 / 104490 (7.9%) | −89.2 | −87.1 | 0.38 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 305 / 10449 (2.9%) | 8074 / 104490 (7.7%) | −89.2 | −87.1 | 0.38 |
| ESR1 SRX2881000 | MCF-7 Breast | 213 / 10449 (2.0%) | 6621 / 104490 (6.3%) | −89.0 | −86.9 | 0.32 |
| ESR1 SRX20282953 | MCF-7 Breast | 196 / 10449 (1.9%) | 6335 / 104490 (6.1%) | −89.0 | −86.9 | 0.31 |
| ESR1 SRX330070 | MCF-7 Breast | 117 / 10449 (1.1%) | 4947 / 104490 (4.7%) | −88.7 | −86.6 | 0.24 |
| Epitope tags SRX15725652 | 293 Kidney | 1102 / 10449 (10.5%) | 5529 / 104490 (5.3%) | −88.7 | −86.6 | 1.99 |
| FOXA1 SRX3931033 | MCF-7 Breast | 145 / 10449 (1.4%) | 5445 / 104490 (5.2%) | −88.4 | −86.3 | 0.27 |
| FOXA1 SRX11222437 | MCF-7 Breast | 171 / 10449 (1.6%) | 5891 / 104490 (5.6%) | −88.3 | −86.2 | 0.29 |
| ESR1 SRX1012629 | MCF-7 Breast | 145 / 10449 (1.4%) | 5440 / 104490 (5.2%) | −88.2 | −86.2 | 0.27 |
| ZFX SRX7805370 | 293 Kidney | 695 / 10449 (6.7%) | 2787 / 104490 (2.7%) | −88.0 | −86.0 | 2.49 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 223 / 10449 (2.1%) | 6728 / 104490 (6.4%) | −87.5 | −85.5 | 0.33 |
| JUNB SRX8488088 | SUM 229PE Breast | 469 / 10449 (4.5%) | 10405 / 104490 (10.0%) | −87.5 | −85.5 | 0.45 |
| FOXA1 SRX1447317 | MCF-7 Breast | 154 / 10449 (1.5%) | 5570 / 104490 (5.3%) | −87.4 | −85.3 | 0.28 |
| ERG SRX063918 | MCF-7 Breast | 891 / 10449 (8.5%) | 4090 / 104490 (3.9%) | −87.2 | −85.1 | 2.18 |
| FOXA1 SRX219284 | LNCAP Prostate | 328 / 10449 (3.1%) | 8346 / 104490 (8.0%) | −87.1 | −85.1 | 0.39 |
| BRD4 SRX1272808 | COLO 741 Digestive tract | 778 / 10449 (7.4%) | 3340 / 104490 (3.2%) | −87.0 | −84.9 | 2.33 |
| Epitope tags SRX15725650 | 293 Kidney | 981 / 10449 (9.4%) | 4716 / 104490 (4.5%) | −86.9 | −84.9 | 2.08 |
| KDM4C SRX424010 | KYSE-150 Digestive tract | 737 / 10449 (7.1%) | 3077 / 104490 (2.9%) | −86.9 | −84.9 | 2.40 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 220 / 10449 (2.1%) | 6653 / 104490 (6.4%) | −86.7 | −84.7 | 0.33 |
| STAT1 SRX23678708 | K-562 Blood | 910 / 10449 (8.7%) | 4229 / 104490 (4.0%) | −86.7 | −84.6 | 2.15 |
| INTS3 SRX3640569 | HeLa Uterus | 767 / 10449 (7.3%) | 3274 / 104490 (3.1%) | −86.7 | −84.6 | 2.34 |
| ESR1 SRX330069 | MCF-7 Breast | 146 / 10449 (1.4%) | 5406 / 104490 (5.2%) | −86.6 | −84.5 | 0.27 |
| G3BP1 SRX24196609 | KGN Gonad | 975 / 10449 (9.3%) | 4691 / 104490 (4.5%) | −86.3 | −84.2 | 2.08 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 261 / 10449 (2.5%) | 7290 / 104490 (7.0%) | −86.3 | −84.2 | 0.36 |
| FOXA1 SRX3931032 | MCF-7 Breast | 136 / 10449 (1.3%) | 5215 / 104490 (5.0%) | −86.3 | −84.2 | 0.26 |
| FOXA1 SRX028635 | MCF-7 Breast | 116 / 10449 (1.1%) | 4851 / 104490 (4.6%) | −86.2 | −84.2 | 0.24 |
| ESR1 SRX1012633 | MCF-7 Breast | 121 / 10449 (1.2%) | 4940 / 104490 (4.7%) | −86.2 | −84.1 | 0.24 |
| FOXA1 SRX1961157 | T-47D Breast | 263 / 10449 (2.5%) | 7317 / 104490 (7.0%) | −86.1 | −84.1 | 0.36 |
| AR SRX1067067 | LHSAR Prostate | 411 / 10449 (3.9%) | 9520 / 104490 (9.1%) | −86.0 | −84.0 | 0.43 |
| NR3C1 SRX19024866 | MCF-7 Breast | 79 / 10449 (0.8%) | 4130 / 104490 (4.0%) | −86.0 | −84.0 | 0.19 |
| HEXIM1 SRX1177905 | HCT 116 Digestive tract | 1096 / 10449 (10.5%) | 5558 / 104490 (5.3%) | −85.9 | −83.9 | 1.97 |
| ESR1 SRX1469949 | MCF-7 Breast | 136 / 10449 (1.3%) | 5200 / 104490 (5.0%) | −85.8 | −83.8 | 0.26 |
| FOXA1 SRX1787654 | MCF-7 Breast | 81 / 10449 (0.8%) | 4163 / 104490 (4.0%) | −85.8 | −83.7 | 0.19 |
| ESR1 SRX3123829 | MCF-7 Breast | 135 / 10449 (1.3%) | 5180 / 104490 (5.0%) | −85.7 | −83.7 | 0.26 |
| HDAC1 SRX20517420 | Keratinocytes Epidermis | 1002 / 10449 (9.6%) | 4893 / 104490 (4.7%) | −85.7 | −83.7 | 2.05 |
| AFF1 SRX2281250 | SEM Blood | 581 / 10449 (5.6%) | 2128 / 104490 (2.0%) | −85.7 | −83.7 | 2.73 |
| CDK9 SRX20230573 | Ishikawa Uterus | 1298 / 10449 (12.4%) | 7054 / 104490 (6.8%) | −85.5 | −83.5 | 1.84 |
| NANOG SRX10445309 | Neural crest cells Neural | 131 / 10449 (1.3%) | 5094 / 104490 (4.9%) | −85.2 | −83.2 | 0.26 |
| ARID1A SRX5089379 | MCF-7 Breast | 243 / 10449 (2.3%) | 6970 / 104490 (6.7%) | −85.2 | −83.2 | 0.35 |
| ESR1 SRX1161186 | ZR-75-1 Breast | 71 / 10449 (0.7%) | 3942 / 104490 (3.8%) | −85.2 | −83.2 | 0.18 |
| KDM5A SRX23740431 | SUM 149PT Breast | 878 / 10449 (8.4%) | 4049 / 104490 (3.9%) | −85.1 | −83.1 | 2.17 |
| KAT6A DRX366109 | 293 Kidney | 1221 / 10449 (11.7%) | 6492 / 104490 (6.2%) | −85.1 | −83.1 | 1.88 |
| ESR1 SRX5323873 | MCF-7 Breast | 302 / 10449 (2.9%) | 7872 / 104490 (7.5%) | −85.0 | −83.0 | 0.38 |
| FOS SRX4192879 | MCF 10A Breast | 288 / 10449 (2.8%) | 7659 / 104490 (7.3%) | −85.0 | −82.9 | 0.38 |
| EP300 SRX1012644 | MCF-7 Breast | 106 / 10449 (1.0%) | 4626 / 104490 (4.4%) | −84.9 | −82.9 | 0.23 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 442 / 10449 (4.2%) | 1350 / 104490 (1.3%) | −84.7 | −82.7 | 3.27 |
| SREBF2 SRX5359049 | HCC70 Breast | 713 / 10449 (6.8%) | 2961 / 104490 (2.8%) | −84.7 | −82.7 | 2.41 |
| MED1 SRX4937340 | HCT 116 Digestive tract | 957 / 10449 (9.2%) | 4602 / 104490 (4.4%) | −84.7 | −82.7 | 2.08 |
| BRD2 SRX8090652 | Synoviocytes Others | 708 / 10449 (6.8%) | 2933 / 104490 (2.8%) | −84.6 | −82.6 | 2.41 |
| ESR1 SRX330068 | MCF-7 Breast | 110 / 10449 (1.1%) | 4688 / 104490 (4.5%) | −84.6 | −82.6 | 0.23 |
| FOXA1 SRX3931056 | MCF-7 Breast | 140 / 10449 (1.3%) | 5229 / 104490 (5.0%) | −84.4 | −82.4 | 0.27 |
| Epitope tags SRX10715360 | HCB1 Blood | 680 / 10449 (6.5%) | 2758 / 104490 (2.6%) | −84.4 | −82.4 | 2.47 |
| ESR1 SRX3110725 | MCF-7 Breast | 223 / 10449 (2.1%) | 6622 / 104490 (6.3%) | −84.4 | −82.4 | 0.34 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 85 / 10449 (0.8%) | 4201 / 104490 (4.0%) | −84.4 | −82.4 | 0.20 |
| ESR1 SRX2912055 | MCF-7 Breast | 91 / 10449 (0.9%) | 4320 / 104490 (4.1%) | −84.3 | −82.3 | 0.21 |
| NANOG SRX5286326 | hESC WIBR2 Pluripotent stem cell | 205 / 10449 (2.0%) | 6330 / 104490 (6.1%) | −84.3 | −82.3 | 0.32 |
| ZNF711 SRX7805362 | 293 Kidney | 871 / 10449 (8.3%) | 4025 / 104490 (3.9%) | −84.0 | −82.0 | 2.16 |
| Crotonyllysine SRX12306536 | Polycystic kidney Kidney | 926 / 10449 (8.9%) | 4403 / 104490 (4.2%) | −84.0 | −82.0 | 2.10 |
| RBM22 SRX4708083 | K-562 Blood | 556 / 10449 (5.3%) | 2004 / 104490 (1.9%) | −83.9 | −81.9 | 2.77 |
| KMT2A SRX2281247 | SEM Blood | 972 / 10449 (9.3%) | 4727 / 104490 (4.5%) | −83.9 | −81.9 | 2.06 |
| CREBBP SRX359409 | 293 Kidney | 942 / 10449 (9.0%) | 4517 / 104490 (4.3%) | −83.9 | −81.9 | 2.09 |
| Epitope tags SRX392690 | T3M-1 Cl-10 Others | 115 / 10449 (1.1%) | 41 / 104490 (0.0%) | −83.8 | −81.8 | 28.05 |
| KAT7 DRX234808 | 293 Kidney | 468 / 10449 (4.5%) | 1504 / 104490 (1.4%) | −83.8 | −81.8 | 3.11 |
| ESR1 SRX10365533 | MCF-7 Breast | 115 / 10449 (1.1%) | 4759 / 104490 (4.6%) | −83.8 | −81.8 | 0.24 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 270 / 10449 (2.6%) | 7335 / 104490 (7.0%) | −83.7 | −81.7 | 0.37 |
| ESR1 SRX4451212 | MCF-7 Breast | 232 / 10449 (2.2%) | 6738 / 104490 (6.4%) | −83.7 | −81.7 | 0.34 |
| MYOCD SRX5598318 | A549 Lung | 995 / 10449 (9.5%) | 4895 / 104490 (4.7%) | −83.6 | −81.7 | 2.03 |
| RBFOX2 SRX3322781 | K-562 Blood | 1192 / 10449 (11.4%) | 6323 / 104490 (6.1%) | −83.5 | −81.5 | 1.89 |
| ESR1 SRX792933 | LY2 Breast | 204 / 10449 (2.0%) | 6280 / 104490 (6.0%) | −83.4 | −81.4 | 0.32 |
| CEBPB SRX150632 | HeLa Uterus | 556 / 10449 (5.3%) | 11437 / 104490 (10.9%) | −83.4 | −81.4 | 0.49 |
| NANOG SRX017277 | hESC H1 Pluripotent stem cell | 88 / 10449 (0.8%) | 4227 / 104490 (4.0%) | −83.1 | −81.1 | 0.21 |
| ESR1 SRX10365558 | MCF-7 Breast | 168 / 10449 (1.6%) | 5668 / 104490 (5.4%) | −83.0 | −81.0 | 0.30 |
| ESR1 SRX20282959 | MCF-7 Breast | 100 / 10449 (1.0%) | 4449 / 104490 (4.3%) | −82.9 | −80.9 | 0.22 |
| NR3C1 SRX19024870 | MCF-7 Breast | 78 / 10449 (0.7%) | 4021 / 104490 (3.8%) | −82.9 | −80.9 | 0.19 |
| RBFOX2 SRX3323051 | Hep G2 Liver | 901 / 10449 (8.6%) | 4254 / 104490 (4.1%) | −82.9 | −80.9 | 2.12 |
| JUN SRX4192884 | MCF 10A Breast | 210 / 10449 (2.0%) | 6356 / 104490 (6.1%) | −82.8 | −80.8 | 0.33 |
| EP300 SRX176883 | MCF-7 Breast | 113 / 10449 (1.1%) | 4688 / 104490 (4.5%) | −82.7 | −80.8 | 0.24 |
| FOXA1 SRX5323845 | MCF-7 Breast | 86 / 10449 (0.8%) | 4174 / 104490 (4.0%) | −82.7 | −80.8 | 0.21 |
| ESR1 SRX20282971 | MCF-7 Breast | 250 / 10449 (2.4%) | 6989 / 104490 (6.7%) | −82.7 | −80.7 | 0.36 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 235 / 10449 (2.2%) | 6749 / 104490 (6.5%) | −82.6 | −80.6 | 0.35 |
| GATA1 SRX4172744 | HCT 116 Digestive tract | 897 / 10449 (8.6%) | 4235 / 104490 (4.1%) | −82.5 | −80.6 | 2.12 |
| Epitope tags SRX14024876 | Mesenchymal stem cells Others | 1314 / 10449 (12.6%) | 7266 / 104490 (7.0%) | −82.4 | −80.4 | 1.81 |
| FOXA1 SRX1161203 | T-47D Breast | 176 / 10449 (1.7%) | 5775 / 104490 (5.5%) | −82.2 | −80.2 | 0.30 |
| FOXA1 SRX11222442 | MCF-7 Breast | 163 / 10449 (1.6%) | 5557 / 104490 (5.3%) | −82.2 | −80.2 | 0.29 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 238 / 10449 (2.3%) | 6784 / 104490 (6.5%) | −82.2 | −80.2 | 0.35 |
| FOXA1 SRX3923516 | MCF-7 Breast | 177 / 10449 (1.7%) | 5785 / 104490 (5.5%) | −82.0 | −80.1 | 0.31 |
| CEBPA SRX2630241 | Hep G2 Liver | 303 / 10449 (2.9%) | 7781 / 104490 (7.4%) | −82.0 | −80.1 | 0.39 |
| ESR1 SRX8537722 | MCF-7 Breast | 236 / 10449 (2.3%) | 6736 / 104490 (6.4%) | −81.8 | −79.8 | 0.35 |
| TRPS1 SRX3401273 | MCF-7 Breast | 81 / 10449 (0.8%) | 4047 / 104490 (3.9%) | −81.7 | −79.8 | 0.20 |
| FOXA1 SRX5203303 | MCF-7 Breast | 83 / 10449 (0.8%) | 4085 / 104490 (3.9%) | −81.7 | −79.7 | 0.20 |
| FOXA1 SRX1447316 | MCF-7 Breast | 100 / 10449 (1.0%) | 4410 / 104490 (4.2%) | −81.5 | −79.6 | 0.23 |
| AR SRX9469987 | LAPC-4 Prostate | 118 / 10449 (1.1%) | 4743 / 104490 (4.5%) | −81.5 | −79.5 | 0.25 |
| FOXA1 SRX11222438 | MCF-7 Breast | 128 / 10449 (1.2%) | 4919 / 104490 (4.7%) | −81.5 | −79.5 | 0.26 |
| GFP SRX12567763 | MRC-5 Lung | 985 / 10449 (9.4%) | 4881 / 104490 (4.7%) | −81.3 | −79.4 | 2.02 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 225 / 10449 (2.2%) | 6540 / 104490 (6.3%) | −81.1 | −79.2 | 0.34 |
| FOXA1 SRX15430999 | T-47D Breast | 278 / 10449 (2.7%) | 7363 / 104490 (7.0%) | −81.0 | −79.0 | 0.38 |
| FOXA1 SRX1961158 | T-47D Breast | 248 / 10449 (2.4%) | 6898 / 104490 (6.6%) | −81.0 | −79.0 | 0.36 |
| FOXA1 SRX3923517 | MCF-7 Breast | 176 / 10449 (1.7%) | 5733 / 104490 (5.5%) | −80.9 | −79.0 | 0.31 |
| FOXA1 SRX6878603 | LNCAP Prostate | 282 / 10449 (2.7%) | 7421 / 104490 (7.1%) | −80.9 | −78.9 | 0.38 |
| ESR1 SRX1012630 | MCF-7 Breast | 94 / 10449 (0.9%) | 4273 / 104490 (4.1%) | −80.9 | −78.9 | 0.22 |
| FOXA1 SRX17794420 | 22Rv1 Prostate | 165 / 10449 (1.6%) | 5547 / 104490 (5.3%) | −80.8 | −78.9 | 0.30 |
| STAT1 SRX23678707 | K-562 Blood | 842 / 10449 (8.1%) | 3897 / 104490 (3.7%) | −80.8 | −78.9 | 2.16 |
| FOXA1 SRX5323846 | MCF-7 Breast | 88 / 10449 (0.8%) | 4154 / 104490 (4.0%) | −80.7 | −78.7 | 0.21 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 206 / 10449 (2.0%) | 6219 / 104490 (6.0%) | −80.6 | −78.7 | 0.33 |
| FOXA1 SRX100477 | Hep G2 Liver | 287 / 10449 (2.7%) | 7481 / 104490 (7.2%) | −80.6 | −78.6 | 0.38 |
| KDM5A SRX23740430 | SUM 149PT Breast | 977 / 10449 (9.4%) | 4844 / 104490 (4.6%) | −80.5 | −78.6 | 2.02 |
| RBFOX2 SRX3322782 | K-562 Blood | 1117 / 10449 (10.7%) | 5855 / 104490 (5.6%) | −80.5 | −78.5 | 1.91 |
| FOXA1 SRX3923518 | MCF-7 Breast | 169 / 10449 (1.6%) | 5601 / 104490 (5.4%) | −80.4 | −78.5 | 0.30 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 171 / 10449 (1.6%) | 5630 / 104490 (5.4%) | −80.4 | −78.5 | 0.30 |
| PROX1 SRX3230397 | Hep G2 Liver | 183 / 10449 (1.8%) | 5832 / 104490 (5.6%) | −80.4 | −78.4 | 0.31 |
| FOXA1 SRX3923519 | MCF-7 Breast | 151 / 10449 (1.4%) | 5290 / 104490 (5.1%) | −80.4 | −78.4 | 0.29 |
| EP300 SRX1012643 | MCF-7 Breast | 90 / 10449 (0.9%) | 4180 / 104490 (4.0%) | −80.3 | −78.4 | 0.22 |
| FOXA1 SRX5203294 | MCF-7 Breast | 69 / 10449 (0.7%) | 3758 / 104490 (3.6%) | −80.1 | −78.2 | 0.18 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 217 / 10449 (2.1%) | 6379 / 104490 (6.1%) | −80.1 | −78.2 | 0.34 |
| ESR1 SRX1531796 | MCF-7 Breast | 137 / 10449 (1.3%) | 5038 / 104490 (4.8%) | −80.1 | −78.2 | 0.27 |
| ESR1 SRX1469951 | MCF-7 Breast | 132 / 10449 (1.3%) | 4950 / 104490 (4.7%) | −80.1 | −78.2 | 0.27 |
| DOT1L SRX10606582 | GIST-T1 Digestive tract | 984 / 10449 (9.4%) | 4902 / 104490 (4.7%) | −80.1 | −78.2 | 2.01 |
| SSRP1 SRX3436566 | HT-1080 Bone | 186 / 10449 (1.8%) | 234 / 104490 (0.2%) | −80.0 | −78.1 | 7.95 |
| ESR1 SRX1012628 | MCF-7 Breast | 128 / 10449 (1.2%) | 4870 / 104490 (4.7%) | −79.9 | −77.9 | 0.26 |
| ESR1 SRX2897217 | Breast cancer cells Breast | 571 / 10449 (5.5%) | 2159 / 104490 (2.1%) | −79.9 | −77.9 | 2.64 |
| TEAD1 SRX3401272 | MCF-7 Breast | 200 / 10449 (1.9%) | 6091 / 104490 (5.8%) | −79.8 | −77.9 | 0.33 |
| ESR1 SRX20282938 | MCF-7 Breast | 208 / 10449 (2.0%) | 6218 / 104490 (6.0%) | −79.7 | −77.8 | 0.33 |
| ESR1 SRX5323878 | MCF-7 Breast | 255 / 10449 (2.4%) | 6957 / 104490 (6.7%) | −79.7 | −77.7 | 0.37 |
| KMT2A SRX1293531 | MV-4-11 Blood | 1478 / 10449 (14.1%) | 8615 / 104490 (8.2%) | −79.6 | −77.7 | 1.72 |
| ZNF711 SRX7805363 | 293 Kidney | 898 / 10449 (8.6%) | 4311 / 104490 (4.1%) | −79.6 | −77.7 | 2.08 |
| ZEB1 SRX13298925 | MCF-7 Breast | 158 / 10449 (1.5%) | 5377 / 104490 (5.1%) | −79.4 | −77.5 | 0.29 |
| CNOT3 SRX886388 | Colorectal carcinoma Digestive tract | 1126 / 10449 (10.8%) | 5948 / 104490 (5.7%) | −79.4 | −77.5 | 1.89 |
| CDK9 SRX20230572 | Ishikawa Uterus | 1007 / 10449 (9.6%) | 5085 / 104490 (4.9%) | −79.4 | −77.4 | 1.98 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 266 / 10449 (2.5%) | 7116 / 104490 (6.8%) | −79.3 | −77.4 | 0.37 |
| BCOR SRX10184493 | K-562 Blood | 1266 / 10449 (12.1%) | 6996 / 104490 (6.7%) | −79.3 | −77.4 | 1.81 |
| ARID1A SRX5089388 | MCF-7 Breast | 131 / 10449 (1.3%) | 4901 / 104490 (4.7%) | −79.1 | −77.2 | 0.27 |
| Epitope tags SRX7276677 | 293 Kidney | 1563 / 10449 (15.0%) | 9300 / 104490 (8.9%) | −79.1 | −77.2 | 1.68 |
| BRD2 SRX8090642 | Synoviocytes Others | 652 / 10449 (6.2%) | 2677 / 104490 (2.6%) | −79.0 | −77.1 | 2.44 |
| Epitope tags SRX4192708 | MDA-MB-231 Breast | 609 / 10449 (5.8%) | 2407 / 104490 (2.3%) | −78.9 | −77.0 | 2.53 |
| KAT6B DRX411443 | 293 Kidney | 1248 / 10449 (11.9%) | 6874 / 104490 (6.6%) | −78.9 | −77.0 | 1.82 |
| KAT6B DRX411444 | 293 Kidney | 1234 / 10449 (11.8%) | 6768 / 104490 (6.5%) | −78.9 | −76.9 | 1.82 |
| ESR1 SRX5323877 | MCF-7 Breast | 199 / 10449 (1.9%) | 6032 / 104490 (5.8%) | −78.6 | −76.7 | 0.33 |
| VGLL1 SRX18013277 | FULVR Breast | 111 / 10449 (1.1%) | 4517 / 104490 (4.3%) | −78.4 | −76.5 | 0.25 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 241 / 10449 (2.3%) | 6699 / 104490 (6.4%) | −78.4 | −76.5 | 0.36 |
| CEBPA SRX4705113 | MOLM-13 Blood | 588 / 10449 (5.6%) | 11651 / 104490 (11.2%) | −78.4 | −76.5 | 0.50 |
| FOXA1 SRX3923511 | MCF-7 Breast | 90 / 10449 (0.9%) | 4124 / 104490 (3.9%) | −78.4 | −76.5 | 0.22 |
| ESR1 SRX10365534 | MCF-7 Breast | 76 / 10449 (0.7%) | 3846 / 104490 (3.7%) | −78.3 | −76.4 | 0.20 |
| NR3C1 SRX1161181 | ZR-75-1 Breast | 71 / 10449 (0.7%) | 3741 / 104490 (3.6%) | −78.2 | −76.3 | 0.19 |
| FOXA1 SRX5203307 | MCF-7 Breast | 74 / 10449 (0.7%) | 3802 / 104490 (3.6%) | −78.1 | −76.2 | 0.19 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 247 / 10449 (2.4%) | 6779 / 104490 (6.5%) | −78.1 | −76.2 | 0.36 |
| KDM5A SRX23740438 | SUM 149PT Breast | 998 / 10449 (9.6%) | 5056 / 104490 (4.8%) | −78.0 | −76.2 | 1.97 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 221 / 10449 (2.1%) | 6365 / 104490 (6.1%) | −78.0 | −76.1 | 0.35 |
| FOXA1 SRX9604647 | LNCAP Prostate | 392 / 10449 (3.8%) | 8926 / 104490 (8.5%) | −78.0 | −76.1 | 0.44 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 171 / 10449 (1.6%) | 5547 / 104490 (5.3%) | −77.9 | −76.0 | 0.31 |
| FOXA1 SRX1161205 | T-47D Breast | 135 / 10449 (1.3%) | 4921 / 104490 (4.7%) | −77.6 | −75.7 | 0.27 |
| GATA3 SRX5457550 | MCF-7 Breast | 296 / 10449 (2.8%) | 7508 / 104490 (7.2%) | −77.6 | −75.7 | 0.39 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 69 / 10449 (0.7%) | 3679 / 104490 (3.5%) | −77.5 | −75.6 | 0.19 |
| CHD7 SRX3581504 | iPS cells Pluripotent stem cell | 49 / 10449 (0.5%) | 3253 / 104490 (3.1%) | −77.4 | −75.5 | 0.15 |
| ESR1 SRX5323872 | MCF-7 Breast | 262 / 10449 (2.5%) | 6982 / 104490 (6.7%) | −77.4 | −75.5 | 0.38 |
| Epitope tags SRX12024485 | Polycystic kidney Kidney | 1531 / 10449 (14.7%) | 9110 / 104490 (8.7%) | −77.3 | −75.4 | 1.68 |
| FOXA1 SRX5323829 | T-47D Breast | 146 / 10449 (1.4%) | 5103 / 104490 (4.9%) | −77.3 | −75.4 | 0.29 |
| ESR1 SRX5323871 | MCF-7 Breast | 284 / 10449 (2.7%) | 7312 / 104490 (7.0%) | −77.2 | −75.3 | 0.39 |
| FOXA1 SRX2017929 | LNCAP Prostate | 346 / 10449 (3.3%) | 8231 / 104490 (7.9%) | −77.1 | −75.2 | 0.42 |
| FOXA1 SRX3931031 | MCF-7 Breast | 123 / 10449 (1.2%) | 4691 / 104490 (4.5%) | −76.9 | −75.1 | 0.26 |
| ESR1 SRX1012631 | MCF-7 Breast | 114 / 10449 (1.1%) | 4525 / 104490 (4.3%) | −76.9 | −75.0 | 0.25 |
| SUZ12 SRX10184494 | K-562 Blood | 1441 / 10449 (13.8%) | 8437 / 104490 (8.1%) | −76.3 | −74.4 | 1.71 |
| NR3C1 SRX1161182 | ZR-75-1 Breast | 61 / 10449 (0.6%) | 3480 / 104490 (3.3%) | −76.2 | −74.4 | 0.18 |
| SOX2 SRX5771668 | N2102Ep Gonad | 65 / 10449 (0.6%) | 3560 / 104490 (3.4%) | −76.1 | −74.3 | 0.18 |
| NANOG SRX3288567 | hESC H9 Pluripotent stem cell | 94 / 10449 (0.9%) | 4127 / 104490 (3.9%) | −76.1 | −74.2 | 0.23 |
| ARID1A SRX5089391 | MCF-7 Breast | 153 / 10449 (1.5%) | 5182 / 104490 (5.0%) | −76.0 | −74.2 | 0.30 |
| ARID1A SRX5089382 | MCF-7 Breast | 188 / 10449 (1.8%) | 5767 / 104490 (5.5%) | −76.0 | −74.1 | 0.33 |
| ZEB1 SRX13298923 | MCF-7 Breast | 110 / 10449 (1.1%) | 4427 / 104490 (4.2%) | −76.0 | −74.1 | 0.25 |
| NR3C1 SRX19024880 | MCF-7 Breast | 65 / 10449 (0.6%) | 3556 / 104490 (3.4%) | −76.0 | −74.1 | 0.18 |
| TFAP2C SRX018833 | MCF-7 Breast | 242 / 10449 (2.3%) | 6623 / 104490 (6.3%) | −76.0 | −74.1 | 0.37 |
| NUP98 SRX20440536 | Keratinocytes Epidermis | 274 / 10449 (2.6%) | 604 / 104490 (0.6%) | −75.9 | −74.1 | 4.54 |
| FOXA1 SRX3923515 | MCF-7 Breast | 145 / 10449 (1.4%) | 5043 / 104490 (4.8%) | −75.9 | −74.0 | 0.29 |
| TFAP2C SRX128099 | MCF-7 Breast | 242 / 10449 (2.3%) | 6620 / 104490 (6.3%) | −75.8 | −74.0 | 0.37 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 150 / 10449 (1.4%) | 5120 / 104490 (4.9%) | −75.7 | −73.9 | 0.29 |
| SOX13 SRX2636248 | Hep G2 Liver | 363 / 10449 (3.5%) | 8421 / 104490 (8.1%) | −75.7 | −73.8 | 0.43 |
| SETD1A SRX23734380 | MOLM-13 Blood | 613 / 10449 (5.9%) | 2491 / 104490 (2.4%) | −75.7 | −73.8 | 2.46 |
| VGLL1 SRX24602130 | BT-20 Breast | 282 / 10449 (2.7%) | 7226 / 104490 (6.9%) | −75.6 | −73.8 | 0.39 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 242 / 10449 (2.3%) | 6607 / 104490 (6.3%) | −75.6 | −73.7 | 0.37 |
| STAT3 SRX150479 | MCF 10A Breast | 251 / 10449 (2.4%) | 6744 / 104490 (6.5%) | −75.5 | −73.6 | 0.37 |
| LEO1 SRX15147190 | DLD-1 Digestive tract | 494 / 10449 (4.7%) | 1767 / 104490 (1.7%) | −75.4 | −73.6 | 2.80 |
| MethylCap SRX026646 | Acute myeloid leukemia Blood | 379 / 10449 (3.6%) | 1125 / 104490 (1.1%) | −75.4 | −73.5 | 3.37 |
| Epitope tags SRX8080559 | Mammary gland adenocarcinoma Breast | 112 / 10449 (1.1%) | 4439 / 104490 (4.2%) | −75.3 | −73.4 | 0.25 |
| NANOG SRX2881137 | hESC H9 Pluripotent stem cell | 76 / 10449 (0.7%) | 3756 / 104490 (3.6%) | −75.3 | −73.4 | 0.20 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 172 / 10449 (1.6%) | 5477 / 104490 (5.2%) | −75.2 | −73.4 | 0.31 |
| ESR1 SRX2901942 | Ishikawa Uterus | 686 / 10449 (6.6%) | 2972 / 104490 (2.8%) | −75.1 | −73.3 | 2.31 |
| FOXA1 SRX497612 | VCaP Prostate | 251 / 10449 (2.4%) | 6732 / 104490 (6.4%) | −75.1 | −73.2 | 0.37 |
| EP300 SRX2671820 | iPS cells Pluripotent stem cell | 57 / 10449 (0.5%) | 3365 / 104490 (3.2%) | −75.1 | −73.2 | 0.17 |
| HMG20A SRX2630163 | Hep G2 Liver | 151 / 10449 (1.4%) | 5116 / 104490 (4.9%) | −75.0 | −73.1 | 0.30 |
| CEBPB SRX190345 | MCF-7 Breast | 202 / 10449 (1.9%) | 5953 / 104490 (5.7%) | −74.9 | −73.0 | 0.34 |
| FOXA1 SRX6860635 | T-47D Breast | 202 / 10449 (1.9%) | 5955 / 104490 (5.7%) | −74.9 | −73.0 | 0.34 |
| FOXA1 SRX9604645 | LNCAP Prostate | 372 / 10449 (3.6%) | 8514 / 104490 (8.1%) | −74.9 | −73.0 | 0.44 |
| FOXA1 SRX1161207 | T-47D Breast | 108 / 10449 (1.0%) | 4352 / 104490 (4.2%) | −74.8 | −73.0 | 0.25 |
| NANOG SRX13437668 | hESC H1 Pluripotent stem cell | 39 / 10449 (0.4%) | 2960 / 104490 (2.8%) | −74.8 | −73.0 | 0.13 |
| ESR1 SRX2513520 | MCF-7 Breast | 172 / 10449 (1.6%) | 5462 / 104490 (5.2%) | −74.8 | −73.0 | 0.31 |
| NCOA3 SRX4663589 | MCF-7 Breast | 75 / 10449 (0.7%) | 3721 / 104490 (3.6%) | −74.8 | −72.9 | 0.20 |
| WAS SRX5371250 | GM11518 Blood | 631 / 10449 (6.0%) | 2623 / 104490 (2.5%) | −74.6 | −72.8 | 2.41 |
| GTF3C1 SRX4636577 | 293 Kidney | 762 / 10449 (7.3%) | 3490 / 104490 (3.3%) | −74.6 | −72.7 | 2.18 |
| KMT2A SRX8151120 | VDH-15 Others | 1194 / 10449 (11.4%) | 6594 / 104490 (6.3%) | −74.6 | −72.7 | 1.81 |
| PGR SRX1012654 | MCF-7 Breast | 92 / 10449 (0.9%) | 4042 / 104490 (3.9%) | −74.4 | −72.6 | 0.23 |
| ESR1 SRX8537723 | MCF-7 Breast | 216 / 10449 (2.1%) | 6160 / 104490 (5.9%) | −74.4 | −72.6 | 0.35 |
| DNMT3B SRX2862487 | hESC HUES8 Pluripotent stem cell | 169 / 10449 (1.6%) | 206 / 104490 (0.2%) | −74.2 | −72.3 | 8.20 |
| ESR1 SRX5534831 | MCF-7 Breast | 210 / 10449 (2.0%) | 6055 / 104490 (5.8%) | −74.2 | −72.3 | 0.35 |
| STAT5A SRX9681372 | ARP-1 Blood | 797 / 10449 (7.6%) | 3740 / 104490 (3.6%) | −74.0 | −72.1 | 2.13 |
| MAU2 SRX11120893 | MCF-7 Breast | 108 / 10449 (1.0%) | 4323 / 104490 (4.1%) | −74.0 | −72.1 | 0.25 |
| ESR1 SRX11120903 | MCF-7 Breast | 236 / 10449 (2.3%) | 6455 / 104490 (6.2%) | −73.9 | −72.0 | 0.37 |
| FOXA1 SRX5323830 | T-47D Breast | 161 / 10449 (1.5%) | 5245 / 104490 (5.0%) | −73.9 | −72.0 | 0.31 |
| ESR1 SRX1012625 | MCF-7 Breast | 145 / 10449 (1.4%) | 4974 / 104490 (4.8%) | −73.8 | −72.0 | 0.29 |
| BMI1 SRX8726297 | Tumor Others | 901 / 10449 (8.6%) | 4472 / 104490 (4.3%) | −73.7 | −71.9 | 2.01 |
| FOXA1 SRX6878604 | LNCAP Prostate | 220 / 10449 (2.1%) | 6194 / 104490 (5.9%) | −73.6 | −71.8 | 0.36 |
| FOXA1 SRX219285 | LNCAP Prostate | 253 / 10449 (2.4%) | 6701 / 104490 (6.4%) | −73.4 | −71.6 | 0.38 |
| SOX2 SRX512370 | iPS cells Pluripotent stem cell | 44 / 10449 (0.4%) | 3030 / 104490 (2.9%) | −73.4 | −71.5 | 0.15 |
| SMARCA2 SRX8119677 | MeT-5A Others | 441 / 10449 (4.2%) | 9426 / 104490 (9.0%) | −73.3 | −71.5 | 0.47 |
| BCORL1 SRX10184496 | K-562 Blood | 1147 / 10449 (11.0%) | 6282 / 104490 (6.0%) | −73.3 | −71.5 | 1.83 |
| NANOG SRX702040 | hESC HUES64 Pluripotent stem cell | 54 / 10449 (0.5%) | 3245 / 104490 (3.1%) | −73.2 | −71.4 | 0.17 |
| ESR1 SRX4451214 | MCF-7 Breast | 239 / 10449 (2.3%) | 6473 / 104490 (6.2%) | −73.1 | −71.3 | 0.37 |
| STAT3 SRX150630 | MCF 10A Breast | 255 / 10449 (2.4%) | 6716 / 104490 (6.4%) | −73.1 | −71.2 | 0.38 |
| ESR1 SRX2578880 | MDA-MB-231 Breast | 795 / 10449 (7.6%) | 3749 / 104490 (3.6%) | −73.0 | −71.2 | 2.12 |
| FOXA1 SRX3923508 | MCF-7 Breast | 82 / 10449 (0.8%) | 3805 / 104490 (3.6%) | −73.0 | −71.1 | 0.22 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 287 / 10449 (2.7%) | 7190 / 104490 (6.9%) | −72.8 | −71.0 | 0.40 |
| ESR1 SRX2513517 | MCF-7 Breast | 187 / 10449 (1.8%) | 5637 / 104490 (5.4%) | −72.8 | −71.0 | 0.33 |
| KDM6A SRX15826236 | MCF-7 Breast | 86 / 10449 (0.8%) | 3876 / 104490 (3.7%) | −72.7 | −70.9 | 0.22 |
| ESR1 SRX2513521 | MCF-7 Breast | 134 / 10449 (1.3%) | 4744 / 104490 (4.5%) | −72.7 | −70.9 | 0.28 |
| JUNB SRX4192882 | MCF 10A Breast | 222 / 10449 (2.1%) | 6194 / 104490 (5.9%) | −72.7 | −70.9 | 0.36 |
| CREBBP SRX359408 | 293 Kidney | 758 / 10449 (7.3%) | 3502 / 104490 (3.4%) | −72.6 | −70.8 | 2.16 |
Showing first 500 of 14972 rows.